Digital Repository

First co-infection of malaria and hepatitis E diagnosed in Sri Lanka

Show simple item record

dc.contributor.author Senarathne, S.
dc.contributor.author Rajapakse, S.
dc.contributor.author de Silva, H.J.
dc.contributor.author Seneviratne, S.
dc.contributor.author Chulasiri, P.
dc.contributor.author Fernando, D.
dc.date.accessioned 2023-10-25T07:07:20Z
dc.date.available 2023-10-25T07:07:20Z
dc.date.issued 2023
dc.identifier.citation Sri Lanka Medical Association, 136th Anniversary International Medical Congress. 2023; 68 (Supplement S):S101 en_US
dc.identifier.issn 0009-0875
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/26788
dc.description Poster Presentation Abstract (PP 049), 136th Anniversary International Medical Congress, Sri Lanka Medical Association, 25th-28th July 2023, Colombo, Sri Lanka en_US
dc.description.abstract INTRODUCTION: Imported malaria cases continue to be reported in Sri Lanka. Similarly, hepatitis E is also considered a travel associated imported disease in Sri Lanka. This is a report of the first co-infection of malaria and hepatitis E in Sri Lanka. OBJECTIVES: A 21-year-old European who visited Sri Lanka after a 2 months stay in India, was admitted to hospital with fever, vomiting, abdominal pain, and dark-coloured urine on the 4th day after his arrival. On examination, he had splenomegaly but no hepatomegaly. He had thrombocytopaenia; 89% neutrophils; 9% lymphocytes; elevated liver enzymes and hyperbilirubinaemia. Urine was positive for bile pigment. METHODS: Considering his travel history to India, he was tested for malaria. The rapid diagnostic test became positive for Plasmodium falciparum while microscopy showed P. falciparum ring stages with a parasite density of 120/μl. He was treated as for uncomplicated P. falciparum malaria with oral Artemisinin-based Combination Therapy. The patient became fever-free and blood smears became negative after 13 hours following 2 doses of antimalarials. RESULTS: However, his liver functions were further deranged with apparent jaundice (ALT: 250 U/L; AST: 175 U/L; ALP: 130 U/L; GGT: 179 U/L; total bilirubin: 10.65 mg/dL; direct bilirubin: 8.08 mg/dL; indirect bilirubin: 2.57 mg/dL). Further blood tests detected hepatitis E-specific IgM antibodies. He was treated with oral ursodiol but no specific antiviral was given. Following the completion of antimalarials, he was discharged from the hospital upon clinical recovery. CONCLUSION: Clinicians should be vigilant on travel-associated co-infections in patients who are diagnosed with imported malaria. en_US
dc.language.iso en en_US
dc.publisher Sri Lanka Medical Association en_US
dc.subject malaria en_US
dc.subject hepatitis E en_US
dc.subject co-infections en_US
dc.title First co-infection of malaria and hepatitis E diagnosed in Sri Lanka en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • Conference Papers
    Papers presented at local and international conferences by the Staff of the Faculty of Medicine

Show simple item record

Search Digital Repository


Browse

My Account